Status:
COMPLETED
An Observational Study on Incidence, Natural History and Treatment Patterns of Venous Thromboembolism in Taiwan
Lead Sponsor:
Bayer
Conditions:
Venous Thromboembolism
Eligibility:
All Genders
20+ years
Brief Summary
The research question addressed by this study is primarily on the clinical epidemiology of VTE in Taiwan. The study aims to estimate the incidence of VTE and describe natural history of VTE, including...
Eligibility Criteria
Inclusion
- The source population was the adult population in Taiwan. The legal age for definition as an adult (without additional research ethics review requirement) in Taiwan is 20; therefore all National Health Insurance (NHI) enrollees age 20 or older at any time during the study period were evaluated for VTE.
Exclusion
- Person-time before an eligible subject turned 20 were not evaluated.
- Study subjects having inconsistent data on gender and unrealistic date of birth (birth year before 1890 and after 2015) were identified and excluded from the analysis.
Key Trial Info
Start Date :
December 15 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2017
Estimated Enrollment :
104215 Patients enrolled
Trial Details
Trial ID
NCT03799016
Start Date
December 15 2016
End Date
July 1 2017
Last Update
January 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei, Taiwan